Cases 1 - 5 of 5
In re: Leatha Taylor, et al v. Bristol-Myers Squibb Company, et al
as 22-6078
Not Classified By Court:
In re: ONGLYZA (SAXAGLIPTIN) AND KOMBIGLYZE (SAXAGLIPTIN AND METFORMIN) PRODUCTS LIABILITY LITIGATION MDL 2809
Plaintiff / Appellant:
LEATHA TAYLOR, Individually and as Administratrix of Estate of David Taylor, KATHY BARNES, LISA ARLENE PEOPLES and others
Defendant / Appellee:
BRISTOL-MYERS SQUIBB COMPANY, ASTRAZENECA PHARMACEUTICALS LP, IPR PHARMACEUTICALS INC. and others
Ware v. Bristol-Myers Squibb Company et al
as 5:2018cv00067
Plaintiff:
Charles David Ware
Defendant:
Bristol-Myers Squibb Company , AstraZeneca Pharmaceuticals LP and McKesson Corporation
Cause Of Action: 28 U.S.C. § 1332
In re: Onglyza (Saxagliptin) and Kombiglyze (Saxagliptin and Metformin) Products Liability Litigation MDL 2809
as 5:2018md02809
Defendant:
Onglyza (Saxagliptin) and Kombiglyze (Saxagliton and Metformin) Products Liability Litigation MDL 2809, McKesson Corporation, Bristol-Myers Squibb Company, Inc. and others
Plaintiff:
Susan Settle, Charles David Ware, William Dinger Sr. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Ware v. Bristol-Myers Squibb Company et al
as TXE/1:17-cv-00111
Plaintiff:
Charles David Ware
Defendant:
Bristol-Myers Squibb Company , AstraZeneca Pharmaceuticals LP and McKesson Corporation
Ware v. Bristol-Myers Squibb Company et al
as 1:2017cv00111
Plaintiff:
Charles David Ware
Defendant:
Bristol-Myers Squibb Company, AstraZeneca Pharmaceuticals LP and McKesson Corporation
Cause Of Action: 28 U.S.C. § 1332
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
